SGLT2 inhibitors promote glucosuria by inhibiting glucose reabsorption in the proximal renal tubule, and the associated suppression of insulin secretion and stimulation of glucagon secretion protect against hypoglycemia [14]. The gene discussed is GCG; the disease is Hypoglycemia.